Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for the Treatment of Alcohol Use Disorder
NCT06727331Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2025
- Primary completion
- Mar 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in alcohol use disorder (AUD), sponsored by Brigham and Women's Hospital. Started Sep 2025; status: recruiting.
02
Drugs
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT06727331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06727331.